Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
This study is a prospective observational study in which a female patient who received IV Artesunate while pregnant can volunteer to provide information about her pregnancy and the outcome of her pregnancy. Information will be collected from patient's provider, the patient's obstetrician, the child's pediatrician, or other relevant healthcare provider.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 15
Maximum Age: 100
Healthy Volunteers: f
View:
• Patient received IV Artesunate
• Patient was pregnant while receiving IV Artesunate
• Patient was at least 15 years of age
• Patient or legal guardian/representative gave consent for the study and to collect data from her physicians
Locations
United States
New Jersey
4C Pharma Solutions
RECRUITING
Piscataway
Contact Information
Primary
Katrina Riggs
kriggs@fastttrackresearch.com
3017622609
Time Frame
Start Date: 2022-06-08
Estimated Completion Date: 2029-07-01
Participants
Target number of participants: 25
Related Therapeutic Areas
Sponsors
Leads: Amivas Inc.